Novo Nordisk (NVO) -1.2% after discontinuing a phase-3 trial with NovoSeven, a treatment for severe bleeding.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Mon, 5:23PM)
at Investor's Business Daily (Feb 20, 2015)
at Benzinga.com (Feb 20, 2015)
at Benzinga.com (Jan 14, 2015)
at Investor's Business Daily (Jan 8, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs